Advertisement
Research Article| Volume 56, ISSUE 5, P308-316, September 01, 2004

Download started.

Ok

Animal modeling dual diagnosis schizophrenia: Sensitization to cocaine in rats with neonatal ventral hippocampal lesions

  • R. Andrew Chambers
    Correspondence
    Address reprint requests to R. Andrew Chambers, M.D., Institute of Psychiatric Research, Indiana University School of Medicine, 791 Union Drive, Indianapolis, IN 46202
    Affiliations
    Laboratory for Translational Neuroscience of Dual Diagnosis Disorders (RAC), Institute of Psychiatric Research, Indiana University School of Medicine, Indianapolis, Indiana
    Search for articles by this author
  • Jane R. Taylor
    Affiliations
    Division of Molecular Psychiatry (JRT), Connecticut Mental Health Center, Yale University School of Medicine, New Haven, Connecticut, USA
    Search for articles by this author

      Background

      Increased substance disorder comorbidity in schizophrenia may reflect greater vulnerability to addictive processes because of inherent neurocircuit dysfunction in the schizophrenic brain.

      Methods

      To further explore this hypothesis, we used neonatal ventral hippocampal lesions (NVHL) as a rat model of schizophrenia and assessed locomotor sensitization to cocaine (15 mg/kg) in adulthood.

      Results

      The NVHL animals showed greater activity in response to an initial cocaine injection compared with sham and saline-treated groups. With daily cocaine injections over 7 days, NVHL rats showed elevated locomotor sensitization curves with greater fluctuations in the intersession changes in activity between days 4 and 7. In a single session 4 weeks later, NVHL compared with SHAM rats showed maintenance of cocaine-associated hyperactivity, as if superimposed on long-term sensitization effects present in both groups.

      Conclusions

      In a neurodevelopmental model of schizophrenia, the locomotor effects of cocaine were augmented on initial and repeated doses, with emergence of irregularity in sensitization-related changes in activity in the short term and perseverance of augmented effects in the long term. Altered patterns of behavioral sensitization, as a possible correlate of greater addiction vulnerability, can occur as a by-product of neural systems dysfunction responsible for major psychiatric syndromes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

        • Arnold S.E.
        • Franz B.R.
        • Gur R.C.
        • Gur R.E.
        • Shapiro R.M.
        • Moberg P.J.
        • Trojanowski J.Q.
        Smaller neuron size in hippocampal subfields that mediate cortical-hippocampal interactions.
        Am J Psychiatry. 1995; 152: 738-748
        • Becker A.
        • Grecksch G.
        Social memory is impaired in neonatally ibotenic acid lesioned rats.
        Behav Brain Res. 2000; 109: 137-140
        • Bogarts B.
        • Lieberman J.A.
        • Ashtari M.
        • Bilder R.M.
        • Degreef G.
        • Lerner G
        • et al.
        Hippocampus-amygdala volumes and psychopathology in schizophrenia.
        Biol Psychiatry. 1993; 33: 236-246
        • Boutros N.N.
        • Bowers M.B.
        • Quinlan D.
        Chronological association between increases in drug abuse and psychosis in Connecticut state hospitals.
        J Neuropsych Clin Neurosci. 1998; 10: 48-54
        • Brady K.T.
        • Lydiard R.B.
        • Malcom R.
        • Ballenger J.
        Cocaine-induced psychosis.
        J Clin Psychiatry. 1991; 52: 509-512
        • Chambers R.A.
        • Krystal J.K.
        • Self D.W.
        A neurobiological basis for substance abuse comorbidity in schizophrenia.
        Biol Psychiatry. 2001; 50: 71-83
        • Chambers R.A.
        • Moore J.
        • McEvoy J.P.
        • Levin E.D.
        Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.
        Neuropsychopharmaclogy. 1996; 15: 587-594
        • Chambers R.A.
        • Self D.W.
        Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions.
        Neuropsychopharmacology. 2002; 27: 889-905
        • Chambers R.A.
        • Sheehan T.
        • Taylor J.R.
        Locomotor sensitization to cocaine in rats with olfactory bulbectomy.
        Synapse. 2004; 52: 167-175
        • Chambers R.A.
        • Taylor J.R.
        • Potenza M.N.
        Developmental neurocircuitry of motivation in adolescence.
        Am J Psychiatry. 2003; 160: 1041-1052
        • Crow T.J.
        • Deakin J.F.W.
        • Longden A.
        The nucleus accumbens-possible site of action of antipsychotic action of neuroleptic drugs.
        Phys Med. 1977; 7: 213-221
        • Cuffel B.J.
        Comorbid substance use disorder.
        New Dir Ment Health Serv. 1996; 70: 93-9105
        • De Vries T.J.
        • Schoffelmeer A.N.M.
        • Binnekade R.
        • Halfdan R.
        • Vanderschuren J.M.J.
        Relapse to cocaine and heroin-seeking behavior mediated by dopamine D2 receptors is time dependent and associated with behavioral sensitization.
        Neuropsychopharmacology. 2002; 26: 18-26
        • Dixon L.
        Dual diagnosis of substance abuse in schizophrenia.
        Schizophrenia Res. 1999; 35: S93-S100
        • Drake R.E.
        • Wallach M.A.
        Dual diagnosis.
        Psychiatr Serv. 2000; 51: 1126-1129
        • Everitt B.J.
        • Wolf M.E.
        Psychomotor stimulant addiction.
        J Neurosci. 2002; 22: 3312-3320
        • Finch D.M.
        Neurophysiology of converging synaptic inputs from the rat prefrontal cortex, amygdala, midline thalamus, and hippocampal formation onto single neurons of the caudat/putamen and nucleus accumbens.
        Hippocampus. 1996; 6: 495-512
        • Gerdeman G.L.
        • Partridge J.G.
        • Lupica C.R.
        • Lovinger D.M.
        It could be habit forming.
        Trend Neurosci. 2003; 26: 184-192
        • Goto Y.
        • O'Donnell P.
        Delayed mesolimbic system alteration in a developmental animal model of schizophrenia.
        J Neurosci. 2002; 22: 9070-9077
        • Grecksch G.
        • Bernstein H.G.
        • Becker A.
        • Hollt V.
        • Bogerts B.
        Disruption of latent inhibition in rats with posttnatal hippocampal lesions.
        Neuropsychopharmacology. 1999; 20: 525-532
        • Holmes P.V.
        • Masini C.V.
        • Primeaux S.D.
        • Garrett J.L.
        • Zellner A.
        • Stogner K.S.
        • Duncan A.A
        • et al.
        Intravenous self-administration of amphetamine in a rat model of depression.
        Synapse. 2002; 46: 4-10
        • Jentsch J.D.
        • Taylor J.R.
        Impulsivity resulting from frontostriatal dysfunction in drug abuse.
        Psychopharmacology. 1999; 146: 373-390
        • Kelly J.P.
        • Wrynn A.S.
        • Leonard B.E.
        The olfactory bulbectomized rat as a model of depression.
        Pharamacol Ther. 1997; 74: 299-316
        • Le Pen G.
        • Grottick A.J.
        • Higgins G.A.
        • Martin J.R.
        • Jenck F.
        • Moreau J.L.
        Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats.
        Behav Pharmacol. 2000; 11: 257-268
        • Lillrank S.M.
        • Lipska B.K.
        • Bachus S.E.
        • Wood G.K.
        • Weinberger D.R.
        Amphetamine-induced c-fos mRNA expression is altered in rats with neonatal ventral hippocampal damage.
        Synapse. 1996; 23: 292-301
        • Lillrank S.M.
        • Lipska B.K.
        • Kolachana B.S.
        Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage.
        J Neural Transm. 1999; 106: 183-196
        • Lillrank S.M.
        • Lipska B.K.
        • Weinberger D.R.
        • Fredholm B.B.
        • Fuxe K.
        • Ferre S.
        Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: Lack of changes after a neonatal bilateral lesion of the ventral hippocampus.
        Neurochem Int. 1999; 34: 235-244
        • Lipska B.K.
        • Chrapusta S.J.
        • Egan M.F.
        • Weinberger D.R.
        Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol.
        Synapse. 1995; 20: 125-130
        • Lipska B.K.
        • Jaskiw G.E.
        • Weinberger D.R.
        Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage.
        Neuropsychopharmacology. 1993; 9: 67-75
        • Lipska B.K.
        • Swerdlo N.R.
        • Geyer M.A.
        • Jaskiw G.E.
        • Braff D.L.
        • Weinberger D.R.
        Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine.
        Psychopharmacology. 1995; 122: 35-43
        • Lipska B.K.
        • Weinberger D.R.
        Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.
        Neuropsychopharmacology. 1994; 10: 199-205
        • O'Donnell P.
        • Lewis B.L.
        • Weinberger D.R.
        • Lipska B.
        Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats.
        Cereb Cortex. 2002; 12: 975-982
        • O'Donnell P.O.
        • Grace A.A.
        Synaptic interactions among excitatory afferents to the nucleus accumbens neurons.
        J Neurosci. 1995; 15: 3622-3639
        • Piazza P.V.
        • Deminiere J.M.
        • Le Moal M.
        • Simon H.
        Factors that predict individual vulnerability to amphetamine self-administration.
        Science. 1989; 245: 1511-1513
        • Post R.M.
        Cocaine psychosis.
        Am J Psychiatry. 1975; 132: 225-231
        • Robinson T.E.
        • Berridge K.C.
        The neural basis of drug craving.
        Brain Res Rev. 1993; 18: 247-291
        • Sams-Dodd F.
        • Lipska B.K.
        • Weinberger D.R.
        Neonatal lesions of the rat ventral hippocampus results in hyperlocomotion and deficits in social behavior in adulthood.
        Psychopharmacology. 1997; 132: 303-310
        • Schroeder H.
        • Grecksch G.
        • Becker A.
        • Bogerts B.
        • Hoellt V.
        Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion.
        Psychopharmacology. 1999; 145: 61-66
        • Siegfried N.
        A review of comorbidity.
        Aus N Z J Psychiatry. 1998; 32: 707-717
        • Vanderschuren L.
        • Kalivas P.
        Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization.
        Psychopharmacology. 2000; 151: 99-9120
        • Wan R.
        • Giovanni A.
        • Kafka S.H.
        • Corbett R.
        Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine.
        Behav Brain Res. 1996; 78: 211-223
        • Wood G.K.
        • Lipska B.K.
        • Weinberger D.R.
        Behavioral changes in rats with early ventral hippocampal damage vary with age at damage.
        Brain Res Dev Brain Res. 1997; 101: 17-25
        • Wyatt R.J.
        • Damiani L.M.
        • Henter I.D.
        First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
        Br J Psychiatry. 1998; 172: 77-83
        • Yui K.
        • Goto K.
        • Ikemoto S.
        • Ishiguro T.
        • Angrist B.
        • Duncan G.E
        • et al.
        Neurobiological basis of relapse prediction in stimulant induced psychosis and schizophrenia.
        Mol Psychiatry. 1999; 4: 512-523